DIPG / DMG Clinical Trials

NEW: We are now enrolling in the 2.0 beta version of Trial Finder!

Become one of the first users to try out the newest version of the Trial Finder! New features include:

  • Filtering results by keyword
  • Narrowing results to your local area
  • Favorite specific trials
  • Saved searches
  • Customized notifications
  • And more!

Sign-up for Version 2 (Beta)


Trials current as of: 2023-10-04
Viewing 91 clinical trials across 153 countries:

Filter Results:


Clinical Trial
Sponsor
Country
Australia Canada Germany Netherlands United Kingdom United States of America
Nationwide Children's Hospital
United States of America
Milton S. Hershey Medical Center

PEACH TRIAL- Precision Medicine and Adoptive Cellular Therapy
Last Updated: 2023-09-26
Originally Posted: 2021-04-06

United States of America
University of California, San Francisco
United States of America
University of California, San Francisco
United States of America
Brigham and Women's Hospital

MCT for the Harvard/UCSF ROBIN Center
Last Updated: 2023-09-26
Originally Posted: 2023-08-03

Australia Canada Denmark Germany Israel Italy Korea, Republic of Netherlands Spain Switzerland United Kingdom United States of America
Chimerix

ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study)
Last Updated: 2023-09-25
Originally Posted: 2022-09-27

United States of America
Children's National Research Institute

Multi-antigen T Cell Infusion Against Neuro-oncologic Disease
Last Updated: 2023-09-19
Originally Posted: 2018-08-28

United States of America
Ann & Robert H Lurie Children's Hospital of Chicago
United States of America
Mayo Clinic
United Kingdom
University College, London

CAR T Cells to Target GD2 for DMG
Last Updated: 2023-09-06
Originally Posted: 2022-09-13

United States of America
Baylor College of Medicine

C7R-GD2.CAR T Cells for Patients With GD2-expressing Brain Tumors (GAIL-B)
Last Updated: 2023-08-30
Originally Posted: 2019-09-20

United States of America
Nationwide Children's Hospital
United States of America
National Institutes of Health Clinical Center (CC)
United States of America
Augusta University
United States of America
SonALAsense, Inc.
United States of America
Stanford University
United States of America
Children's Oncology Group
Australia Canada New Zealand
University of Calgary

Re-Irradiation of Progressive or Recurrent DIPG
Last Updated: 2023-07-31
Originally Posted: 2017-04-19

Australia United States of America
Aminex Therapeutics, Inc.

Oral AMXT 1501 Dicaprate in Combination With IV DFMO
Last Updated: 2023-07-27
Originally Posted: 2022-08-10

China
Beijing Tiantan Hospital

Neoantigen Vaccine Therapy Against H3.3-K27M Diffuse Intrinsic Pontine Glioma
Last Updated: 2023-07-25
Originally Posted: 2021-02-03

China
Biotech Pharmaceutical Co., Ltd.
Australia Austria Canada France Germany Italy Korea, Republic of United Kingdom United States of America
Blueprint Medicines Corporation
United States of America
St. Jude Children's Research Hospital
United States of America
Bexion Pharmaceuticals, Inc.
Australia Israel Netherlands New Zealand Switzerland United States of America
University of California, San Francisco

Combination Therapy for the Treatment of Diffuse Midline Gliomas
Last Updated: 2023-05-11
Originally Posted: 2021-08-10

United States of America
Northwell Health

A Phase I Study of Mebendazole for the Treatment of Pediatric Gliomas
Last Updated: 2023-04-11
Originally Posted: 2013-04-16

Switzerland United States of America
University of California, San Francisco
Spain
European Organisation for Research and Treatment of Cancer - EORTC
Germany
German Cancer Research Center

A MultIceNTER Phase I Peptide VaCcine Trial for the Treatment of H3-Mutated Gliomas
Last Updated: 2023-03-27
Originally Posted: 2021-03-05

United States of America
Blueprint Medicines Corporation

A Drug-drug Interaction Study of Avapritinib and Midazolam
Last Updated: 2023-03-09
Originally Posted: 2021-05-27

United States of America
Columbia University

FUS Etoposide for DMG - A Feasibility Study
Last Updated: 2023-02-28
Originally Posted: 2023-02-06

Netherlands
Georg-August-Universität Göttingen, Stiftung Öffentlichen Rechts, Universitätsmedizin Göttingen
United States of America
University of Colorado, Denver

Gemcitabine in Newly-Diagnosed Diffuse Intrinsic Pontine Glioma
Last Updated: 2023-02-16
Originally Posted: 2016-11-29

United States of America
Children's National Research Institute
China
Capital Medical University
China
Capital Medical University

Oncolytic Virus Ad-TD-nsIL12 for Primary Pediatric Diffuse Intrinsic Pontine Glioma
Last Updated: 2023-01-29
Originally Posted: 2022-12-18

France
Gustave Roussy, Cancer Campus, Grand Paris

Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication 2.0
Last Updated: 2023-01-27
Originally Posted: 2022-07-25

United States of America
Emory University

Abemaciclib in Children With DIPG or Recurrent/Refractory Solid Tumors
Last Updated: 2023-01-18
Originally Posted: 2015-12-15

United States of America
Nationwide Children's Hospital
United States of America
National Cancer Institute (NCI)

Volitinib in Treating Patients With Recurrent or Refractory Primary CNS Tumors
Last Updated: 2023-01-13
Originally Posted: 2018-07-24

United States of America
Nationwide Children's Hospital
Canada
University of Calgary
United States of America
Children's Hospital Medical Center, Cincinnati
China
Second Affiliated Hospital of Nanchang University
United States of America
Emory University

AflacST1901: Peds WP1066
Last Updated: 2022-07-24
Originally Posted: 2020-04-02

United States of America
National Institutes of Health Clinical Center (CC)
Germany
University of Göttingen

International Cooperative Phase III Trial of the HIT-HGG Study Group (HIT-HGG-2013)
Last Updated: 2022-06-02
Originally Posted: 2017-08-04

India
Tata Memorial Centre
United States of America
Columbia University

CED of MTX110 Newly Diagnosed Diffuse Midline Gliomas
Last Updated: 2022-03-08
Originally Posted: 2020-02-07

United States of America
Chimerix
United States of America
Ann & Robert H Lurie Children's Hospital of Chicago

Post Mortem Tissue Donation of Pediatric Tumor Tissues and Cells
Last Updated: 2021-11-03
Originally Posted: 2021-11-03

United States of America
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
United States of America
University of Cincinnati

Hypofractionated Radiotherapy for Recurrent DIPG
Last Updated: 2021-07-01
Originally Posted: 2019-02-12

Austria
Georg-August-Universität Göttingen, Stiftung Öffentlichen Rechts, Universitätsmedizin Göttingen
United States of America
Weill Medical College of Cornell University
Italy
ENTE OSPEDALIERO OSPEDALI GALLIERA

Diagnostic And Clinical Value Of 64cucl2 In Hgg/dipg
Last Updated: 2021-04-16
Originally Posted: 2021-04-16

Australia
Dr. David Ziegler
China
Shenzhen Geno-Immune Medical Institute

Immune Modulatory DC Vaccine Against Brain Tumor
Last Updated: 2020-06-10
Originally Posted: 2019-04-11

Germany
Georg-August-Universität Göttingen, Stiftung Öffentlichen Rechts, Universitätsmedizin Göttingen
France
Gustave Roussy, Cancer Campus, Grand Paris

Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication
Last Updated: 2018-07-20
Originally Posted: 2014-08-29

Netherlands
Gustave Roussy

Biological Medicine For Diffuse Intrinsic Pontine Glioma (dipg) Eradication
Last Updated: 2017-08-01
Originally Posted: 2017-08-01

Sweden
Gustave Roussy

Biological Medicine For Diffuse Intrinsic Pontine Glioma (dipg) Eradication
Last Updated: 2016-06-22
Originally Posted: 2016-06-22

Denmark
Gustave Roussy

Biological Medicine For Diffuse Intrinsic Pontine Glioma (dipg) Eradication
Last Updated: 2015-09-16
Originally Posted: 2015-09-16

Content courtesy of clinicaltrials.gov, clinicaltrialsregister.eu, and anzctr.org.au